Trade Issues 
COVID-19 issues: Supply chain & Buy American issues 
Importation FDA Patent Settlement legislation 
Intellectual property and patent issues
S. 340, H.R. 965 CREATES Act 
S. 1209, REMEDY Act 
S. 1224, H.R. 2374, Stop STALLING Act Value of Prescription Drugs 
Drug Pricing Transparency  
Oncology Care Model 
Personalized Medicine 
Diagnostics  
S. 1895, Lower Health Care Costs Act
HR 3 Drug pricing bill 
Rebate Reform 
COVID-19 response and legislative/policy changes
        CARES Act 
        Sustainability Medicare Part D Coverage and Reimbursement  
Medicare Part D Non-Interference  
Legislative proposals to change Medicare Part D   
Medicare Part B coverage and reimbursement  
Changes to the Medicaid Drug Rebate Program (AMP Cap) 
Medicare Part B Intl. Pricing Index ANPRM -14 Day Rule
End State Renal Disease PPS
H.R. 107, To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs 
Final Rule: Medicare and Medicaid Programs; Regulation to Require Drug Pricing Transparency
ICD-10 Coding Coordination and Maintenance
        CARES Act Medicare Part D coverage and reimbursement
Value of Prescription Drugs, Senate & House
Prescription Drug Importation, Senate & House
Innovative Payment Models, Senate & House, CMS
Price Transparency, Senate & House 
Legislative proposals to change Medicare Part D
Medicaid and 340B issues & drug discount program
International Pricing Index Model (IPI)
H.R. 1499, Protecting Consumer Access to Generic Drugs Act
S. 1416, Affordable prescriptions for Patients Act
S. 64, H.R. 2375, Preserve Access to Affordable Generics and Biosimilars Act
NPRM: Importation of Prescription drugs
TRD - Trade (domestic/foreign) CPT - Copyright/Patent/Trademark HCR - Health Issues MMM - Medicare/Medicaid PHA - Pharmacy
134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
ASTRAZENECA PHARMACEUTICALS LP
1800 CONCORD PIKE, P.O. BOX 15437, WILMINGTON, DE, 19850, US
CAROLINE QUAT (NA) NATALIE MORRIS JULIE GARNER SUSIE AHN HELEN DWIGHT MORGAN BRADLEY-JONES SUSIE AHN NATALIE MORRIS JULIE GARNER CAROLINE QUAT (NA) NATALIE MORRIS HELEN DWIGHT MORGAN BRADLEY-JONES SUSIE AHN JULIE GARNER CAROLINE QUAT (NA) NATALIE MORRIS HELEN DWIGHT MORGAN BRADLEY-JONES (.) SUSIE AHN JULIE GARNER CAROLINE QUAT (NA) NATALIE MORRIS HELEN DWIGHT MORGAN BRADLEY-JONES SUSIE AHN JULIE GARNER CAROLINE QUAT (NA)
NA NA NA . NA NA